Ozempic Shortage — Why You Can't Find It

Join Dr. Ben Synth as he investigates the shocking truth behind the Ozempic shortage. From a 442% demand surge and counterfeit pens causing comas to a $16 billion manufacturing gamble, discover why the world's most wanted drug keeps vanishing from pharmacy shelves.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth explores Novo Nordisk's unprecedented $16.5 billion manufacturing expansion to end the Ozempic shortage—from fermentation constraints and counterfeit threats to multi-continent factory builds racing against soaring demand. Will massive investments spanning 2027–2029 finally close the gap between a blockbuster molecule and millions needing it?Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth explores the dark side of the Ozempic boom: sophisticated counterfeit pens traced to international networks, FDA seizures, and patient deaths. From Turkish warehouses to U.S. pharmacies, he reveals how desperate demand created a dangerous gray market — and how to protect yourself from fake medications that could be life-threatening.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.

Ben Synth examines how Ozempic became America's most sought-after prescription, overwhelming supply chains with a 442% demand surge in three years. The episode covers viral cultural adoption, manufacturing constraints, the diabetes patient crisis, telehealth's role, and Novo Nordisk's multibillion-dollar expansion as the system struggles to catch up with explosive, ongoing demand.Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTVThis content was created in partnership and with the help of Artificial Intelligence AIThis episode includes AI-generated content.